These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 11069416)
1. Molecular markers for predicting prostate cancer stage and survival. Dunsmuir WD; Gillett CE; Meyer LC; Young MP; Corbishley C; Eeles RA; Kirby RS BJU Int; 2000 Nov; 86(7):869-78. PubMed ID: 11069416 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer. Vis AN; Noordzij MA; Fitoz K; Wildhagen MF; Schröder FH; van der Kwast TH J Urol; 2000 Dec; 164(6):2156-61. PubMed ID: 11061947 [TBL] [Abstract][Full Text] [Related]
3. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features. Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796 [TBL] [Abstract][Full Text] [Related]
4. Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer. Moul JW; Bettencourt MC; Sesterhenn IA; Mostofi FK; McLeod DG; Srivastava S; Bauer JJ Surgery; 1996 Aug; 120(2):159-66; discussion 166-7. PubMed ID: 8751578 [TBL] [Abstract][Full Text] [Related]
5. Value of tissue markers p27(kip1), MIB-1, and CD44s for the pre-operative prediction of tumour features in screen-detected prostate cancer. Vis AN; van Rhijn BW; Noordzij MA; Schröder FH; van der Kwast TH J Pathol; 2002 Jun; 197(2):148-54. PubMed ID: 12015737 [TBL] [Abstract][Full Text] [Related]
6. Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder. Moonen L; Ong F; Gallee M; Verheij M; Horenblas S; Hart AA; Bartelink H Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1305-10. PubMed ID: 11286838 [TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma. Kallakury BV; Sheehan CE; Ambros RA; Fisher HA; Kaufman RP; Ross JS Cancer; 1997 Aug; 80(4):753-63. PubMed ID: 9264360 [TBL] [Abstract][Full Text] [Related]
9. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features. Ioachim E Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860 [TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 overexpression in primary hypopharyngeal carcinomas. Masuda M; Hirakawa N; Nakashima T; Kuratomi Y; Komiyama S Cancer; 1996 Aug; 78(3):390-5. PubMed ID: 8697381 [TBL] [Abstract][Full Text] [Related]
11. Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma. Gelb AB; Sudilovsky D; Wu CD; Weiss LM; Medeiros LJ Cancer; 1997 Nov; 80(9):1768-75. PubMed ID: 9351546 [TBL] [Abstract][Full Text] [Related]
12. p53 accumulation associated with bcl-2, the proliferation marker MIB-1 and survival in patients with prostate cancer subjected to watchful waiting. Borre M; Stausbol-Gron B; Overgaard J J Urol; 2000 Sep; 164(3 Pt 1):716-21. PubMed ID: 10953132 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study. Heeran MC; Høgdall CK; Kjaer SK; Christensen L; Jensen A; Blaakaer J; Christensen IJ; Høgdall EV APMIS; 2013 Dec; 121(12):1177-86. PubMed ID: 23594232 [TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 and MIB-1 immunohistochemistry in ependymomas: a study of 41 cases. Prayson RA Am J Clin Pathol; 1998 Nov; 110(5):629-34. PubMed ID: 9802348 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of immunohistochemical expression of topoisomerase alpha II, MIB-1, p53, E-cadherin, retinoblastoma gene protein product, and HER-2/neu in adrenal and extra-adrenal pheochromocytomas. Gupta D; Shidham V; Holden J; Layfield L Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):267-74. PubMed ID: 11127918 [TBL] [Abstract][Full Text] [Related]
16. Androgen receptor expression in male breast carcinoma: lack of clinicopathological association. Pich A; Margaria E; Chiusa L; Candelaresi G; Dal Canton O Br J Cancer; 1999 Feb; 79(5-6):959-64. PubMed ID: 10070897 [TBL] [Abstract][Full Text] [Related]
17. Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy. Bettencourt MC; Bauer JJ; Sesterhenn IA; Mostofi FK; McLeod DG; Moul JW J Urol; 1996 Sep; 156(3):1064-8. PubMed ID: 8709308 [TBL] [Abstract][Full Text] [Related]
18. The prognostic significance of proliferation-associated nucleolar protein p120 expression in prostate adenocarcinoma: a comparison with cyclins A and B1, Ki-67, proliferating cell nuclear antigen, and p34cdc2. Kallakury BV; Sheehan CE; Rhee SJ; Fisher HA; Kaufman RP; Rifkin MD; Ross JS Cancer; 1999 Apr; 85(7):1569-76. PubMed ID: 10193948 [TBL] [Abstract][Full Text] [Related]
19. The value of EZH2, p27(kip1), BMI-1 and MIB-1 on biopsy specimens with low-risk prostate cancer in selecting men with significant prostate cancer at prostatectomy. Wolters T; Vissers KJ; Bangma CH; Schröder FH; van Leenders GJ BJU Int; 2010 Jul; 106(2):280-6. PubMed ID: 19888978 [TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67. Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]